Skip to main content
Article
PsAID12 Provisionally Endorsed at OMERACT 2018 as Core Outcome Measure to Assess Psoriatic Arthritis-specific Health-related Quality of Life in Clinical Trials
The Journal of Rheumatology (2018)
  • Ana-Maria Orbai
  • Richard Holland
  • Ying Ying Leung
  • William Tillett
  • Niti Goel
  • Robin Christensen
  • Neil McHugh
  • Laure Gossec
  • Maarten de Wit
  • Pil Højgaard
  • Laura C. Coates
  • Philip J. Mease
  • Julie Birt
  • Lara Fallon
  • Oliver FitzGerald
  • Alexis Ogdie
  • Beverly Shea
  • Vibeke Strand
  • Kristina Callis Duffin
  • Peter Tugwell
  • Dorcas Beaton
  • Dafna D. Gladman
Publication Date
December 15, 2018
DOI
10.3899/jrheum.181077
Citation Information
Ana-Maria Orbai, Richard Holland, Ying Ying Leung, William Tillett, et al.. "PsAID12 Provisionally Endorsed at OMERACT 2018 as Core Outcome Measure to Assess Psoriatic Arthritis-specific Health-related Quality of Life in Clinical Trials" The Journal of Rheumatology (2018)
Available at: http://works.bepress.com/philip-mease/320/